US Health Secretary Robert F. Kennedy Jr., along with Deputy Secretary Jim O’Neill, FDA Commissioner Dr. Marty Makary and ...

Compass Pathways fell on Phase 3 data but remains on track for an FDA filing despite dilution risks and volatility. Find out ...

Vinay Prasad's interim replacement has concerns about same drug that drove him out. NIH director says employee critics ...

The new rule comes after a public advisory committee meeting in May that reviewed data showing risks for patients who use opioids over long periods. Those risks include misuse, addiction and overdoses ...

Other states have enacted similar laws that would strip artificial dyes from school meals, but West Virginia's action is the ...

U.S. health officials are cracking down on an opioid-related ingredient being added to drinks, supplements and other products ...

The FDA is mandating new labeling for opioids to better inform patients and healthcare providers about the risks of addiction, misuse, and overdose associated with long-term use.

The FDA has released a report to educate the public regarding the dangers of 7-OH and its distinction from the kratom plant ...

The Food and Drug Administration (FDA) on Tuesday said it is recommending a scheduling action to control certain ...

Laura Loomer reportedly set up a "tip line" for staffers eager to see their "disloyal" colleagues purged. Trump has been ...

The U.S. Food and Drug Administration is taking significant steps in the ongoing fight against the Opioid Crisis.

The FDA has announced new requirements for safety labeling on all opioid pain medications that place renewed emphasis on the risks associated with their long-term use. According to a July 31 news ...